CHAPEL HILL, N.C.--(BUSINESS WIRE)--July 30, 2003--POZEN Inc.
(NASDAQ:POZN), a pharmaceutical company developing therapeutic
advancements in a cost effective manner, today announced it will host
a conference call following the release of financial results for the
second quarter ended June 30, 2003. The company will release results
before the market opens on Tuesday, August 5, 2003. John R. Plachetka,
Pharm.D., POZEN's chairman, president and chief executive officer, and
Matthew E. Czajkowski, chief financial officer, will host the
conference call the same day at 11:00 a.m. Eastern time.
The conference call will be simulcast live on the Internet, and
can be accessed by logging on to www.pozen.com. A replay will be
available for seven days in the Investor Relations section of the
company's website. POZEN's second quarter results release can be
accessed in the News section of www.pozen.com and by clicking on the
release dated August 5, 2003.
POZEN is a pharmaceutical company developing therapeutic
advancements in a cost effective manner. Since its inception, POZEN
has developed the largest and most advanced product pipeline in the
field of migraine. Product development efforts are focused on diseases
with unmet medical needs where POZEN can improve efficacy, safety,
and/or patient convenience. The company's common stock is traded on
The Nasdaq Stock Market under the symbol "POZN."
Chief Financial Officer
Director, Investor Relations